Macroscopic brain architecture changes and white matter pathology in acromegaly: A clinicoradiological study

Pituitary

Volumn 12, Issue 3, 2009, Pages 177-185

  Sievers, C ^a   Samann P G ^a   Dose, T ^a   Dimopoulou, C ^a   Spieler, D ^a   Roemmler, J ^b   Schopohl, J ^b   Mueller, M ^a   Schneider, H J ^a,b   Czisch, M ^a   Pfister, H ^a   Stalla, G K ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acromegaly; Brain volume; Growth hormone; Insulin like growth factor 1; MRI; White matter lesions

Indexed keywords

ACROMEGALY; ADULT; ARTICLE; BRAIN TISSUE; CARDIOVASCULAR DISEASE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GRAY MATTER; HUMAN; HYPERTENSION; MALE; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TISSUE STRUCTURE; WHITE MATTER;

ACROMEGALY; ADULT; AGED; BRAIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 67849101587     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-008-0143-1     Document Type: Article

References (32)

1. Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: Epidemiology, pathogenesis, and management. Endocr Rev 25:102-152. doi: 10.1210/er.2002-0022
2. Bonapart IE, van Domburg R, ten Have SM, de Herder WW, Erdman RA, Janssen JA et al (2005) The 'bio-assay' quality of life might be a better marker of disease activity in acromegalic patients than serum total IGF-I concentrations. Eur J Endocrinol 152:217-224. doi: 10.1530/ eje.1.01838
3. Blickenstorfer E (1953) Psychiatric and genealogic study of 51 cases of acromegaly. Schweiz Arch Neurol Psychiatr 71:371-374
4. Blickenstorfer E (1953) Genealogy and psychopathology of 51 acromegaly patients. Acta Endocrinol (Copenh) 13:123-137
5. Blickenstorfer E (1951) Psychiatry and genealogy of acromegaly; studies from the confines of psychopathology of endocrinology. Arch Psychiatr Nervenkr Z Gesamte. Neurol Psychiatr (Bucur) 186:88-122
6. Bleuler M (1951) Personality changes in pituitary disorders. BMJ 1:580-581
7. Bleuler M (1951) The psychopathology of acromegaly. J Nerv Ment Dis 113:497-511. doi: 10.1097/00005053-195101000-00050
8. Russo VC, Gluckman PD, Feldman EL, Werther GA (2005) The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev 26:916-943. doi: 10.1210/er.2004-0024
9. Aberg MA, Aberg ND, Palmer TD, Alborn AM, Carlsson-Skwirut C, Bang P et al (2003) IGF-I has a direct proliferative effect in adult hippocampal progenitor cells. Mol Cell Neurosci 24:23-40. doi: 10.1016/ S1044-7431(03)00082-4
10. Schneider HJ, Pagotto U, Stalla GK (2003) Central effects of the somatotropic system. Eur J Endocrinol 149:377-392. doi: 10.1530/ eje.0.1490377
11. Ransome MI, Goldshmit Y, Bartlett PF, Waters MJ, Turnley AM (2004) Comparative analysis of CNS populations in knockout mice with altered growth hormone responsiveness. Eur J Neurosci 19:2069-2079. doi: 10.1111/ j.0953-816X.2004.03308.x
12. Ajo R, Cacicedo L, Navarro C, Sanchez-Franco F (2003) Growth hormone action on proliferation and differentiation of cerebral cortical cells from fetal rat. Endocrinology 144:1086-1097. doi: 10.1210/en.2002-220667
13. O'Kusky JR, Ye P, D'Ercole AJ (2000) Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development. J Neurosci 20:8435-8442
14. Aberg MA, Aberg ND, Hedbacker H, Oscarsson J, Eriksson PS (2000) Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J Neurosci 20:2896-2903
15. Beck KD, Powell-Braxton L, Widmer HR, Valverde J, Hefti F (1995) Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 14:717-730. doi: 10.1016/0896-6273(95)90216-3
16. Coculescu M (1999) Blood-brain barrier for human growth hormone and insulin-like growth factor-I. J Pediatr Endocrinol Metab 12:113-124
17. van der Lely AJ, Beckers A, Daly AF, Lamberts SWJ, Clemmons DR (2005) Acromegaly: Pathology, diagnosis and treatment. Taylor & Francis, Boca Raton
18. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K et al (2000) Criteria for cure of acromegaly: A consensus statement. J Clin Endocrinol Metab 85:526-529. doi: 10.1210/jc.85.2.526
19. Ashburner J, Friston KJ (2005) Unified segmentation. Neuroimage 26:839-851. doi: 10.1016/j.neuroimage.2005.02.018
20. O'Sullivan M, Measurement of brain atrophy in subcortical vasculr disease: A comparison of different approaches and the impact of ischaemic lesions. NeuroImage (in press)
21. D'Ercole AJ, Ye P, O'Kusky JR (2002) Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides 36:209-220. doi: 10.1054/npep.2002.0893
22. Carson MJ, Behringer RR, Brinster RL, McMorris FA (1993) Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 10:729-740. doi: 10.1016/ 0896-6273(93)90173-O
23. Hoshaw BA, Malberg JE, Lucki I (2005) Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res 1037:204-208. doi: 10.1016/j.brainres.2005.01.007
24. Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ (2002) Measurement of atrophy in multiple sclerosis: Pathological basis, methodological aspects and clinical relevance. Brain 125:1676-1695. doi: 10.1093/brain/awf177
25. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY et al (1999) Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45:1085-1098. doi: 10.1016/S0006-3223(99)00041-4
26. Giannakopoulos P, Hof PR, Michel JP, Guimon J, Bouras C (1997) Cerebral cortex pathology in aging and Alzheimer's disease: A quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res Brain Res Rev 25:217-245. doi: 10.1016/S0165-0173(97)00023-4
27. Mathern GW, Andres M, Salamon N, Chandra PS, Andre VM, Cepeda C et al (2007) A hypothesis regarding the pathogenesis and epileptogenesis of pediatric cortical dysplasia and hemimegalencephaly based on MRI cerebral volumes and NeuN cortical cell densities. Epilepsia 48(Suppl 5):74-78. doi: 10.1111/j.1528-1167.2007.01292.x
28. Corson PW, Nopoulos P, Miller DD, Arndt S, Andreasen NC (1999) Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry 156:1200-1204
29. Aberg ND, Brywe KG, Isgaard J (2006) Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. ScientificWorldJournal 6:53-80. doi: 10.1100/tsw.2006.22
30. Jongen C, van der Grond J, Kappelle LJ, Biessels GJ, Viergever MA, Pluim JP (2007) Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus. Diabetologia 50:1509-1516. doi: 10.1007/ s00125-007-0688-y
31. de Leeuw FE, de Groot JC, Oudkerk M, Witteman JC, Hofman A, van Gijn J et al (2002) Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 125:765-772. doi: 10.1093/brain/awf077
32. Smith EE, Gurol ME, Eng JA, Engel CR, Nguyen TN, Rosand J et al (2004) White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology 63:1606-1612